SIR ePoster Library

Towards establishing an expected false positive rate for hemodialysis access screening
SIR ePoster library. Caro Monroig A. 03/04/17; 169864; 428
Angeliz Caro Monroig
Angeliz Caro Monroig
Login now to access Regular content available to all registered users.
Abstract
Rate & Comment (0)

Final ID
428

Type
Original Scientific Research-Oral or Pos

Authors
A Caro Monroig1, C Griffith1, J Chittams1, S Trerotola2

Institutions
1University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania Medical Center, Philadelphia, PA

Purpose
To establish a suggested rate of non-intervention for patients referred for hemodialysis access fistulography and to study the clinical and fistulographic variables associated with non-intervention (ie, false positive screening).

Materials & Methods
An access database spanning 2002-2016 was used to identify patients undergoing fistulography without receiving an intervention (eg PTA, stent) for any reason. A baseline non-treatment rate was established from these data. Patients from 2010 to 2016 were then selected to study potential associations between clinical indicators, physical exam and non-treatment status. The inclusion criterion for the non-treatment group (NTG) was presence of abnormal clinical indicator(s) resulting in a fistulogram and receiving no treatment because it was not needed (determined by fistulography and/or flow). A control group (CG) receiving treatment (eg, PTA, stent) was randomly selected within the same time frame. Retrospective medical record and image review were conducted. Follow up included IR follow up and non-IR follow up, depending on availability.

Results
Mean non-treatment rate for the entire study period was 9% (range, 3-14%) and plateaued in the last decade (range 2005-2016 was 9-14%, mean 11%). On physical exam, NTG had a higher proportion of patients with normal thrill than CG (65% vs 9%, p<0.0001) and a higher proportion of aneurysm as a clinical indicator than CG (95% vs. 75%, p<0.0006). On image review, NTG had a higher proportion of aneurysms (50% vs. 25%, p< 00012). On follow up, CG had a higher proportion of IR follow up and revision than NTG (96% vs. 39%, p<0.0001). The hazard of a follow up visit in CG was twice the hazard of a follow up in NTG per unit of time between visits (hazard ratio = 2.054).

Conclusions
An initial suggested non-intervention rate for patients presenting for hemodialysis access fistulogram is 10%. Patients in the NTG have greater odds of presenting with normal physical examination, clinical indicator of aneurysms or fistulographic findings of aneurysms, than those in the CG. Somewhat paradoxically, NTG patients were less likely to require subsequent intervention.

Final ID
428

Type
Original Scientific Research-Oral or Pos

Authors
A Caro Monroig1, C Griffith1, J Chittams1, S Trerotola2

Institutions
1University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania Medical Center, Philadelphia, PA

Purpose
To establish a suggested rate of non-intervention for patients referred for hemodialysis access fistulography and to study the clinical and fistulographic variables associated with non-intervention (ie, false positive screening).

Materials & Methods
An access database spanning 2002-2016 was used to identify patients undergoing fistulography without receiving an intervention (eg PTA, stent) for any reason. A baseline non-treatment rate was established from these data. Patients from 2010 to 2016 were then selected to study potential associations between clinical indicators, physical exam and non-treatment status. The inclusion criterion for the non-treatment group (NTG) was presence of abnormal clinical indicator(s) resulting in a fistulogram and receiving no treatment because it was not needed (determined by fistulography and/or flow). A control group (CG) receiving treatment (eg, PTA, stent) was randomly selected within the same time frame. Retrospective medical record and image review were conducted. Follow up included IR follow up and non-IR follow up, depending on availability.

Results
Mean non-treatment rate for the entire study period was 9% (range, 3-14%) and plateaued in the last decade (range 2005-2016 was 9-14%, mean 11%). On physical exam, NTG had a higher proportion of patients with normal thrill than CG (65% vs 9%, p<0.0001) and a higher proportion of aneurysm as a clinical indicator than CG (95% vs. 75%, p<0.0006). On image review, NTG had a higher proportion of aneurysms (50% vs. 25%, p< 00012). On follow up, CG had a higher proportion of IR follow up and revision than NTG (96% vs. 39%, p<0.0001). The hazard of a follow up visit in CG was twice the hazard of a follow up in NTG per unit of time between visits (hazard ratio = 2.054).

Conclusions
An initial suggested non-intervention rate for patients presenting for hemodialysis access fistulogram is 10%. Patients in the NTG have greater odds of presenting with normal physical examination, clinical indicator of aneurysms or fistulographic findings of aneurysms, than those in the CG. Somewhat paradoxically, NTG patients were less likely to require subsequent intervention.

Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies